- Home
- VIOT vs SKYE Comparison
VIOT vs SKYE Comparison
Compare VIOT & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIOT
- SKYE
- Stock Information
- Founded
- VIOT 2014
- SKYE 2012
- Country
- VIOT China
- SKYE United States
- Employees
- VIOT N/A
- SKYE N/A
- Industry
- VIOT Consumer Electronics/Appliances
- SKYE Biotechnology: Pharmaceutical Preparations
- Sector
- VIOT Consumer Discretionary
- SKYE Health Care
- Exchange
- VIOT Nasdaq
- SKYE Nasdaq
- Market Cap
- VIOT 102.5M
- SKYE 108.3M
- IPO Year
- VIOT 2018
- SKYE N/A
- Fundamental
- Price
- VIOT $1.33
- SKYE $4.23
- Analyst Decision
- VIOT
- SKYE Buy
- Analyst Count
- VIOT 0
- SKYE 6
- Target Price
- VIOT N/A
- SKYE $18.67
- AVG Volume (30 Days)
- VIOT 205.4K
- SKYE 636.8K
- Earning Date
- VIOT 08-26-2024
- SKYE 11-09-2024
- Dividend Yield
- VIOT N/A
- SKYE N/A
- EPS Growth
- VIOT N/A
- SKYE N/A
- EPS
- VIOT N/A
- SKYE N/A
- Revenue
- VIOT $306,754,324.00
- SKYE N/A
- Revenue This Year
- VIOT $22.16
- SKYE N/A
- Revenue Next Year
- VIOT $19.04
- SKYE N/A
- P/E Ratio
- VIOT N/A
- SKYE N/A
- Revenue Growth
- VIOT N/A
- SKYE N/A
- 52 Week Low
- VIOT $0.50
- SKYE $1.44
- 52 Week High
- VIOT $1.94
- SKYE $19.41
- Technical
- Relative Strength Index (RSI)
- VIOT 42.62
- SKYE 47.78
- Support Level
- VIOT $1.23
- SKYE $3.53
- Resistance Level
- VIOT $1.94
- SKYE $4.53
- Average True Range (ATR)
- VIOT 0.21
- SKYE 0.39
- MACD
- VIOT -0.05
- SKYE 0.13
- Stochastic Oscillator
- VIOT 14.08
- SKYE 73.78
About VIOT Viomi Technology Co. Ltd
Viomi Technology Co Ltd along with its subsidiaries provides Internet of Things (IoT) enabled smart home products through its platform. It has developed an IoT Home platform, consisting of an ecosystem of IoT Home portfolio, and home water solutions, together with a suite of complementary consumable products and small appliances and others. Its product offerings include Smart kitchen products like refrigerators, oven steamers, dishwashers, and gas stoves, Other smart products such as air conditioning systems, washing machines, water heaters, smart water kettles, interactive smart screens and other smart devices, and Home water solutions include self-branded and Xiaomi-branded smart water purifiers.
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.